"Gone are the people who acquired the experience to know what doesn't work... Those with sufficient boldness to try something outside the conventional axioms now spend their mornings expanding their LinkedIn contacts," laments Daniel Hoffman, president at Pharmaceutical Business Research Associates, in Pharmalot. The result? Politically savvy, play-it-safe employees, those least likely to drive the changes needed to get pharma growing again. Op-Ed